eHealthMe - Personalized health information & community eHealthMe - Personalized health information & community

Personalized health information & community

All drugs: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
All conditions: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Check symptoms   -   Check drugs   -   Compare drugs   -   Join a support group   -   More tools

Would you have Diarrhea when you have Hepatitis c?

Summary: Diarrhea is found among people with Hepatitis c, especially people who are female, 30-39 old, also have High blood pressure, and take medication Ribavirin.

We study 1,785 people who have Diarrhea and Hepatitis c from FDA and social media. Find out below who they are, other conditions they have and drugs they take.

You are not alone: join a support group for people who have Hepatitis c and Diarrhea >>>


Hepatitis c

Hepatitis c can be treated by Ribavirin, Pegasys, Peginterferon, Incivek. (latest reports from 41,476 Hepatitis C patients)


Diarrhea has been reported by people with high blood pressure, pain, depression, rheumatoid arthritis, osteoporosis. (latest reports from 139,378 Diarrhea patients)

On Apr, 28, 2015: 1,785 people who have hepatitis c and Diarrhea are studied.

Trend of Diarrhea in hepatitis c reports

Gender of people who have hepatitis c and experienced Diarrhea * :


Age of people who have hepatitis c and experienced Diarrhea * :


Severity of the symptom * :

leastmoderateseveremost severe

Top co-existing conditions for these people * :

  1. Hypertension (185 people, 10.36%)
  2. Depression (151 people, 8.46%)
  3. Insomnia (61 people, 3.42%)
  4. Gastrooesophageal reflux disease (60 people, 3.36%)
  5. Pain (57 people, 3.19%)
  6. Anxiety (57 people, 3.19%)
  7. Hiv infection (50 people, 2.80%)
  8. Hypothyroidism (46 people, 2.58%)
  9. Anaemia (45 people, 2.52%)
  10. Diarrhoea (41 people, 2.30%)

Most common drugs used by these people * :

  1. Ribavirin (1,785 people, 100.00%)
  2. Pegasys (1,734 people, 97.14%)
  3. Peg-intron (1,584 people, 88.74%)
  4. Incivek (911 people, 51.04%)
  5. Rebetol (728 people, 40.78%)
  6. Copegus (581 people, 32.55%)
  7. Ribasphere (399 people, 22.35%)
  8. Victrelis (185 people, 10.36%)
  9. Lisinopril (120 people, 6.72%)
  10. Lexapro (113 people, 6.33%)

* Approximation only. Some reports may have incomplete information.

How to use the study: print a copy of the study and bring it to your health teams to ensure drug risks and benefits are fully discussed and understood.

Get connected: join our support group of hepatitis c and diarrhea on

Do you have Hepatitis C and Diarrhea?




You are not alone! Join a support group on :
- support group for people who have Diarrhea and Hepatitis c
- support group for people who have Hepatitis c
- support group for people who have Diarrhea

Could your drug cause:

Other conditions that could cause:

Recent related drug studies (Check your drugs):

Recent Hepatitis C related drug comparison:

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only, and has not been supported by scientific studies or clinical trials unless otherwise stated. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

You may report adverse side effects to the FDA at or 1-800-FDA-1088 (1-800-332-1088).

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.


About - Terms of service - Privacy policy - Press - Testimonials - Contact us -

© 2015 All rights reserved. Use of this site constitutes acceptance of's terms of service and privacy policy.